Secondary Causes of Hypertension

Primary Care - Clinics in Office Practice

Volumn 35, Issue 3, 2008, Pages 489-500

  Taler, Sandra J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MONITORING; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIABETIC NEPHROPATHY; DISEASE CLASSIFICATION; DRUG RESISTANCE; ECHOGRAPHY; ENDOCRINE DISEASE; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY DIAGNOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PHEOCHROMOCYTOMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RENOVASCULAR DISEASE; REVIEW; RISK FACTOR; SEROLOGY; SLEEP APNEA SYNDROME; URODYNAMICS;

ADRENAL GLAND DISEASES; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CAUSALITY; COMORBIDITY; HUMANS; HYPERTENSION; KIDNEY DISEASES; MEDICAL HISTORY TAKING; PHYSICIAN-PATIENT RELATIONS; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; UNITED STATES;

EID: 49349099166     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.06.001     Document Type: Review

References (31)

1. Somers V.K., Dyken M.E., Clary M.P., et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96 4 (1995) 1897-1904
2. Goodfriend T.L., and Calhoun D.A. Resistant hypertension, obesity, sleep apnea and aldosterone: theory and therapy. Hypertension 43 (2004) 518-524
3. Garg J.P., Elliott W.J., Folker A., et al. Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens 18 (2005) 619-626
4. Yakovlevitch M., and Black H.R. Resistant hypertension in a tertiary care clinic. Arch Intern Med 151 (1991) 1786-1792
5. Martell N., Rodriguez-Cerrillo M., Grobbee D.E., et al. High prevalence of secondary hypertension and insulin resistance in patients with refractory hypertension. Blood Press 12 (2003) 149-154
6. Taler S.J., Textor S.C., and Augustine J.E. Resistant hypertension: comparing hemodynamic management to specialist care. Hypertension 39 (2002) 982-988
7. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289 (2003) 2560-2572
8. Calhoun D.A., Jones D., Textor S., et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51 6 (2008) 1403-1419
9. Polonia J., Santos A.R., Gama G.M., et al. Accuracy of twenty-four-hour ambulatory blood pressure monitoring (night-day values) for the diagnosis of secondary hypertension. J Hypertens 13 12 Pt 2 (1995) 1738-1741
10. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification. Ann Intern Med 139 (2003) 137-147
11. United States Renal Data System, National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 2007 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States.
12. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 21 4 (2006) 1104-1108
13. Grobner T., and Prischl F.C. Gadolinium and nephrogenic systemic fibrosis. Kidney Int 72 3 (2007) 260-264
14. Tepel M., van der Giet M., Schwarzfeld C., et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343 3 (2000) 180-184
15. Safian R.D., and Textor S.C. Medical progress: renal artery stenosis. N Engl J Med 344 (2001) 431-442
16. Cooper C.J., Murphy T.P., Matsumoto A., et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 152 1 (2006) 59-66
17. Textor S.C. Renovascular hypertension in 2007: where are we now?. Curr Cardiol Rep 9 6 (2007) 453-461
18. Calhoun D.A., Nishizaka M.K., Zaman M.A., et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40 (2002) 892-896
19. Eide I.K., Torjesen P.A., Drolsum A., et al. Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 22 (2004) 2217-2226
20. Lim P.O., Jung R.T., and MacDonald T.M. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity. J Hum Hypertens 16 (2002) 153-158
21. Tanabe A., Naruse M., Takagi S., et al. Variability in the renin/aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab 88 (2003) 2489-2494
22. Montori V.M., Schwartz G.L., Chapman A.B., et al. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc 76 (2001) 877-882
23. Lenders J.W.M., Pacak K., Walther M.M., et al. Biochemical diagnosis of pheochromocytoma: which test is best?. JAMA 287 (2002) 1427-1434
24. Sawka A.M., Jaeschke R., Singh R.J., et al. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 88 (2003) 553-558
25. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
26. Gonçalves S.C., Martinez D., Gus M., et al. Obstructive sleep apnea and resistant hypertension*: a case-control study. Chest 132 6 (2007) 1858-1862
27. Pratt-Ubunama M.N., Nishizaka M.K., Boedefeld R.L., et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 131 2 (2007) 453-459
28. Becker H.F., Jerrentrup A., Ploch T., et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107 1 (2003) 68-73
29. Narkiewicz K., Kato M., Phillips B.G., et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 100 23 (1999) 2332-2335
30. Brown M.A., Buddle M.L., and Martin A. Is resistant hypertension really resistant?. Am J Hypertens 14 (2001) 1263-1269
31. Zachariah P.K., Sheps S.G., Ilstrup D.M., et al. Blood pressure load-a better determinant of hypertension. Mayo Clin Proc 63 (1988) 1085-1091